Suchergebnisse
Is AGC Inc. - Unsponsored ADR (ASGLY) Outperforming Other Conglomerates Stocks This Year?
For those looking to find strong Conglomerates stocks, it is prudent to search for companies in the group that are outperforming their peers. Is AGC Inc. - Unsponsored ADR (ASGLY) one of those
Why Lear (LEA) is a Top Value Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Is Accel Entertainment (ACEL) Stock Outpacing Its Consumer Discretionary Peers This Year?
Investors interested in Consumer Discretionary stocks should always be looking to find the best-performing companies in the group. Is Accel Entertainment (ACEL) one of those stocks right now? Let's
Can IONQ's Profitability and Execution Challenges Weigh on Growth?
IonQ’s IONQ revenue ramp continues to run ahead of operating leverage as it funds a broad roadmap and platform buildout. In the first quarter of 2026, adjusted EBITDA was a loss of $96.8 million
Down 31.6% in 4 Weeks, Here's Why You Should You Buy the Dip in FTC Solar (FTCI)
A downtrend has been apparent in FTC Solar (FTCI) lately with too much selling pressure. The stock has declined 31.6% over the past four weeks. However, given the fact that it is now in oversold
Down 11.4% in 4 Weeks, Here's Why Telus (TU) Looks Ripe for a Turnaround
Telus (TU) has been beaten down lately with too much selling pressure. While the stock has lost 11.4% over the past four weeks, there is light at the end of the tunnel as it is now in oversold
MakeMyTrip (MMYT) Recently Broke Out Above the 20-Day Moving Average
From a technical perspective, MakeMyTrip (MMYT) is looking like an interesting pick, as it just reached a key level of support. MMYT recently overtook the 20-day moving average, and this suggests a
Reasons to Retain Globus Medical Stock in Your Portfolio for Now
Globus Medical, Inc. GMED is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical
Is It Worth Investing in Lam Research (LRCX) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Analysts Think Ares Capital (ARCC) Is a Good Investment: Is It?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Analysts Think Vertiv (VRT) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is It Worth Investing in Citigroup (C) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Here's Why You Should Add Savara Stock to Your Portfolio Now
Savara SVRA continues to advance Molbreevi (molgramostim inhalation solution), its lead and only late-stage pipeline candidate, for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP)
NetApp's Enterprise AI Bet: Can DataPelago Buyout Accelerate Growth?
AI is transforming enterprise IT at an unprecedented pace. To capitalize on this booming trend, NetApp, Inc. NTAP recently acquired DataPelago, a startup specializing in AI data infrastructure. The
Seeking Clues to Glacier Bancorp (GBCI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Analysts on Wall Street project that Glacier Bancorp (GBCI) will announce quarterly earnings of $0.76 per share in its forthcoming report, representing an increase of 68.9% year over year. Revenues
Universal Health Services (UHS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Analysts on Wall Street project that Universal Health Services (UHS) will announce quarterly earnings of $5.66 per share in its forthcoming report, representing an increase of 5.8% year over year
Exploring Analyst Estimates for Principal Financial (PFG) Q2 Earnings, Beyond Revenue and EPS
Analysts on Wall Street project that Principal Financial (PFG) will announce quarterly earnings of $2.32 per share in its forthcoming report, representing an increase of 7.4% year over year
Seeking Clues to Brown & Brown (BRO) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
In its upcoming report, Brown & Brown (BRO) is predicted by Wall Street analysts to post quarterly earnings of $1.08 per share, reflecting an increase of 4.9% compared to the same period last year
Whirlpool (WHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Wall Street analysts expect Whirlpool (WHR) to post quarterly earnings of $0.08 per share in its upcoming report, which indicates a year-over-year decline of 94%. Revenues are expected to be $3.61
Seeking Clues to Phillips Edison & Company (PECO) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts expect Phillips Edison & Company, Inc. (PECO) to post quarterly earnings of $0.68 per share in its upcoming report, which indicates a year-over-year increase of 6.3%. Revenues


